7
Chapter 2: Intended Use
The IPV
®
-1C is indicated for mobilization of secretions, lung expansion therapy,
and the treatment and prevention of pulmonary atelectasis. It can also provide
supplemental oxygen when used with compressed oxygen.
Patient Population
Indications for Use
Absolute Contraindications
Relative Contraindications
Possible Adverse Reactions
Physiological Benets of TRUE-IPV®
IPV®-1C is for use on pediatric and adult patient populations.
• Untreated tension pneumothorax • Untrained or unskilled operator
• History of pneumothorax • Myocardial infarction
• Recent pneumonectomy • Vomiting
• Pulmonary hemorrhage • Pulmonary air leak
(without functioning chest tube)
• Decreased cardiac output • Increased intracranial pressure
• Pneumothorax • Increased air trapping
• Hyper-oxygenation • Pulmonary air leak
• Pulmonary hemorrhage • Hyperventilation
• Gastric distension • Apnea
• Recruitment of atelectatic lung • Mechanical bronchodilation
• Improved FRC • May improve breathing pattern
• Decreased work of breathing • Increased secretion mobilization